Bioventus Inc (NASDAQ: BVS) is 22.51% higher on its value in year-to-date trading and has touched a low of $5.67 and a high of $14.38 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BVS stock was last observed hovering at around $6.85 in the last trading session, with the day’s gains setting it 0.17%.
Currently trading at $7.02, the stock is 5.08% and 3.55% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.17 million and changing 2.48% at the moment leaves the stock -27.76% off its SMA200. BVS registered -33.14% loss for a year compared to 6-month loss of -33.40%. The firm has a 50-day simple moving average (SMA 50) of $6.7792 and a 200-day simple moving average (SMA200) of $9.71715.
The stock witnessed a 5.41% gain in the last 1 month and extending the period to 3 months gives it a -26.18%, and is 5.41% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.35% over the week and 4.15% over the month.
Bioventus Inc (BVS) has around 930 employees, a market worth around $576.65M and $567.70M in sales. Fwd P/E is 7.92. Profit margin for the company is -5.57%. Distance from 52-week low is 23.81% and -51.18% from its 52-week high. The company has generated returns on investments over the last 12 months (-6.82%).
with sales reaching $146.28M over the same period.The EPS is expected to grow by 44.22% this year, but quarterly earnings will post -1.39% year-over-year. Quarterly sales are estimated to shrink -3.26% in year-over-year returns.
202.0 institutions hold shares in Bioventus Inc (BVS), with institutional investors hold 81.18% of the company’s shares. The shares outstanding are 66.23M, and float is at 45.06M with Short Float at 2.71%. Institutions hold 71.55% of the Float.
The top institutional shareholder in the company is ESSEX WOODLANDS MANAGEMENT, INC. with over 13.02 million shares valued at $74.87 million. The investor’s holdings represent 20.3278 of the BVS Shares outstanding. As of 2024-06-30, the second largest holder is JUNIPER INVESTMENT COMPANY, LLC with 6.83 million shares valued at $39.29 million to account for 10.6684 of the shares outstanding. The other top investors are NANTAHALA CAPITAL MANAGEMENT, LLC which holds 5.34 million shares representing 8.3337 and valued at over $30.7 million, while BLACKROCK INC. holds 3.702 of the shares totaling 2.37 million with a market value of $13.64 million.
Bioventus Inc (BVS) Insider Activity
The most recent transaction is an insider sale by Singleton Mark Leonard, the company’s SVP & CFO. SEC filings show that Singleton Mark Leonard sold 3,875 shares of the company’s common stock on Apr 11 ’25 at a price of $7.57 per share for a total of $29334.0. Following the sale, the insider now owns 0.14 million shares.
Bioventus Inc disclosed in a document filed with the SEC on Apr 11 ’25 that D’Adamio Anthony (SVP & General Counsel) sold a total of 2,958 shares of the company’s common stock. The trade occurred on Apr 11 ’25 and was made at $7.57 per share for $22392.0. Following the transaction, the insider now directly holds 0.13 million shares of the BVS stock.
Still, SEC filings show that on Apr 11 ’25, CHURCH KATRINA J (SVP & Chief Compliance Officer) disposed off 1,283 shares at an average price of $7.57 for $9712.0. The insider now directly holds 55,557 shares of Bioventus Inc (BVS).
